US Company Reports Positive Results for New Alzheimer's Drug in Mid-Stage Trials

A US pharmaceutical company announced that its new Alzheimer's treatment drug has shown effectiveness in slowing symptom progression during mid-stage clinical trials. The company plans to proceed with final-stage trials for potential practical application.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

NHK WorldJapanese48d ago

アルツハイマー病の新薬中間段階の臨床試験で効果米企業

世界で開発競争が進んでいるアルツハイマー病の新しいタイプの治療薬について、アメリカの製薬企業は、症状の進行を抑える効果を、中間段階の臨床試験で確認したと発表しました。今後、実用化に向けて、最終段階の臨床試験を行うとしています。

Read full article →

US Company Reports Positive Results for New Alzheimer's Drug in Mid-Stage Trials

Sources

アルツハイマー病の新薬中間段階の臨床試験で効果米企業

Related Stories

Lionel Richie Hospitalized in Intensive Care After Concert Illness

Lionel Richie Hospitalized in ICU Following St. Louis Concert

Novartis Pauses Autoimmune Cell Therapy Trials Following Patient Deaths

Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue

US Company Reports Positive Results for New Alzheimer's Drug in Mid-Stage Trials

Sources

アルツハイマー病の新薬 中間段階の臨床試験で効果 米企業

Related Stories

Lionel Richie Hospitalized in Intensive Care After Concert Illness

Lionel Richie Hospitalized in ICU Following St. Louis Concert

Novartis Pauses Autoimmune Cell Therapy Trials Following Patient Deaths

Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue

アルツハイマー病の新薬中間段階の臨床試験で効果米企業